Navigation Links
Hypotension in Medical News

AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure

... Fetal/Neonatal Morbidity and Mortality . hypotension in Volume- or Salt-Depleted Patients In ... and/or salt-depleted patients, symptomatic hypotension due particularly to the olmesartan component may ... to amlodipine in AZOR is gradual in onset, acute hypotension has rarely been reported after oral ...

FDA Approves VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma

... (13% vs 7%), abdominal pain upper (12% vs 9%), hypotension (12% vs 3%), dyspepsia (11% vs 7%), ... include new or worsening peripheral neuropathy, hypotension throughout therapy, cardiac and pulmonary ... pain (each 15%), bone pain (14%), back pain and hypotension (each 13%), herpes zoster, nasopharyngitis, upper ...

AZOR(TM) Receives FDA Approval for Treatment of High Blood Pressure

... and/or salt-depleted patients, symptomatic hypotension due particularly to the olmesartan component may ... Mortality in the prescribing information. hypotension in Volume- or Salt-Depleted Patients In patients ... with high doses of diuretics), symptomatic hypotension may occur after initiation of treatment with ...

Video: FDA approves Exforge HCT(R) - the Only High Blood Pressure Treatment to Combine Three Medications in a Single Pill

... or hypersensitivity to other sulfonamide-derived drugs. Excessive hypotension was seen in 0.4% of patients treated with EXFORGE and in 1.7% of patients ... salt-depletion before administering EXFORGE or EXFORGE HCT or symptomatic hypotension may occur. Caution should be observed when initiating therapy with ...

FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications

... dyspepsia (5%-7% vs. 1%-4%), dizziness (10%-13% vs. 4%-11%), orthostatic hypotension (7% vs. 5%), weight gain (7% vs. 1%), increased appetite (12% vs. 6%), ... asthenia (5%-10% vs. 3%-4%), abdominal pain (4%-7% vs. 1%-3%), postural hypotension (4%-7% vs. 1%-2%), pharyngitis (4%-6% vs. 3%), weight gain (5%-6% vs. ...

FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications

... dyspepsia (5%-7% vs. 1%-4%), dizziness (10%-13% vs. 4%-11%), orthostatic hypotension (7% vs. 5%), weight gain (7% vs. 1%), increased appetite (12% vs. 6%), ... asthenia (5%-10% vs. 3%-4%), abdominal pain (4%-7% vs. 1%-3%), postural hypotension (4%-7% vs. 1%-2%), pharyngitis (4%-6% vs. 3%), weight gain (5%-6% vs. ...

Data on VELCADE(R) (Bortezomib) for Injection Based Therapies to be Presented at the International Myeloma Workshop

... with VELCADE therapy include new or worsening peripheral neuropathy, hypotension throughout therapy, cardiac and pulmonary disorders, reversible posterior ... pain in limb and abdominal pain (each 15%), bone pain (14%), back pain and hypotension (each 13%), herpes zoster, nasopharyngitis, upper respiratory tract ...

FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder

... (10% vs 4%), constipation (10% vs 5%), abdominal pain (7% vs 3%), postural hypotension (7% vs 2%), pharyngitis (6% vs 3%), and weight gain (6% vs 3%). The most ... vs 7%), somnolence (12% vs 4%), dizziness (10% vs 4%), and orthostatic hypotension (7% vs 5%). In long-term clinical trials of quetiapine, hyperglycemia ...

Centocor Ortho Biotech Statement on the FDA ODAC Opinion Regarding DOXIL(R) for Treatment of Advanced Breast Cancer

... including, but not limited to, flushing, shortness of breath, facial swelling, headache, chills, back pain, tightness in the chest or throat, and/or hypotension have occurred in up to 10 percent of patients treated with DOXIL. In most patients, these reactions have resolved within several hours to a day once ...

Favorable Vote From FDA Advisory Committee on SEROQUEL Pediatric Supplemental New Drug Applications

... vs. 3%-13%), dizziness (9%-18% vs. 5%-7%), constipation (8%-10% vs. 3%-5%), asthenia (5%-10% vs. 3%-4%), abdominal pain (4%-7% vs. 1%-3%), postural hypotension (4%-7% vs. 1%-2%), pharyngitis (4%-6% vs. 3%), weight gain (5%-6% vs. 1%-3%), lethargy (5% vs. 2%), nasal congestion (5% vs. 3%), SGPT increased (5% ...
Hypotension in Medical Technology

Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results

... in the prescribing information . hypotension in Volume- or Salt-Depleted Patients In ... with high doses of diuretics), symptomatic hypotension may occur after initiation of treatment with ... should start under close medical supervision. If hypotension does occur, the patient should be placed in the ...

New Data Shows Blood Pressure Reduction Therapy with BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure

... AEs included: dizziness (3.4 percent), hypotension (2.2 percent), and/or headache (1.1 percent). ... patients, 2.2%), headache (4 patients, 2.2%), and hypotension (4 patients, 2.2%). Among individual treatment ... Mortality in the prescribing information. hypotension in Volume- or Salt-Depleted Patients In ...

New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure

... Fetal/Neonatal Morbidity and Mortality. hypotension in Volume- or Salt-Depleted Patients In ... and/or salt-depleted patients, symptomatic hypotension due particularly to the olmesartan component may ... to amlodipine in AZOR is gradual in onset, acute hypotension has rarely been reported after oral ...

Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma

... include new or worsening peripheral neuropathy, hypotension throughout therapy, cardiac and pulmonary ... pain (each 15%), bone pain (14%), back pain and hypotension (each 13%), herpes zoster, nasopharyngitis, upper ... (13% vs 7%), abdominal pain upper (12% vs 9%), hypotension (12% vs 3%), dyspepsia (11% vs 7%), ...

Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients

... include new or worsening peripheral neuropathy, hypotension throughout therapy, cardiac and pulmonary ... pain (each 15%), bone pain (14%), back pain and hypotension (each 13%), herpes zoster, nasopharyngitis, upper ... (13% vs 7%), abdominal pain upper (12% vs 9%), hypotension (12% vs 3%), dyspepsia (11% vs 7%), ...

Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients

... include new or worsening peripheral neuropathy, hypotension throughout therapy, cardiac and pulmonary ... pain (each 15%), bone pain (14%), back pain and hypotension (each 13%), herpes zoster, nasopharyngitis, upper ... (13% vs 7%), abdominal pain upper (12% vs 9%), hypotension (12% vs 3%), dyspepsia (11% vs 7%), ...

New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients

... (13% vs 7%), abdominal pain upper (12% vs 9%), hypotension (12% vs 3%), dyspepsia (11% vs ... include new or worsening peripheral neuropathy, hypotension throughout therapy, cardiac and pulmonary ... pain (each 15%), bone pain (14%), back pain and hypotension (each 13%), herpes zoster, nasopharyngitis, upper ...

FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL)

... as the incidence (%) in these 98 patients: hypotension (50%), back pain (30%), dyspnea (28%), ... type of treatment will depend on whether edema or hypotension is the primary clinical problem. Pre-existing low ... (61%), infection (48%), pain (48%), edema (47%), hypotension (36%), anorexia (36%), and rash (34%). ...

Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations

... Morbidity and Mortality. hypotension in Volume- or Salt-Depleted Patients In ... salt-depleted patients, symptomatic hypotension due particularly to the olmesartan component may ... to amlodipine in AZOR is gradual in onset, acute hypotension has rarely been reported after ...

New Studies on Once-Daily Extended Release Pramipexole Presented at American Academy of Neurology Annual Meeting

... resulted in accidents. Hallucinations and postural (orthostatic) hypotension may occur. In clinical trials for early PD using immediate release ... of pramipexole that were more frequent than with placebo are postural hypotension (53% vs. 48%), dyskinesia (47% vs. 31%), extrapyramidal syndrome (28% vs. ...

More>>

Hypotension in Medical Definition

Space medicine

... edema and other unwelcome side effects. Upon return to earth, the blood begins to pool in the lower extremities again, resulting in orthostatic hypotension . External links Description of space medicine References http://science.nasa.gov/headlines/y2002/25mar_dizzy.htm ...
Hypotension in Medical Dictionary

Hypotension

... hypotension , orthostatic: A temporary lowering of blood pressure ( hypotension ) due usually to suddenly standing up (orthostatic). Postural hypotension is especially common in older adults who are ...

Low blood pressure

... with dizzy spells . Low blood pressure ( hypotension ) may also cause an ischemic stroke , although ... red blood cells) ... Low blood pressure ( hypotension ) Light-headedness, fainting Lupus reaction ... Muscle cramps Digitalis toxicity ... hypotension ( Low Blood Pressure ) SYMPTOMS"There are ...

Fainting

... too long. Fainting may also result from low blood pressure , or hypotension , often when someone stands up suddenly or is dehydrated and low in body ... - Source:MedicineNet Low Blood Pressure - Low blood pressure ( hypotension ) is blood pressure below normal. Low blood pressure symptoms vary, ...

Multiple system atrophy

... syndrome , which is also known as multiple system atrophy with postural hypotension . Search All of MedicineNet For: search help Printer-Friendly Format ... ... by the following: ... Multiple system atrophy with orthostatic hypotension . Also called Shy-Drager syndrome , this rare disorder causes progressive ...

Palpitation

... Their cardiovascular effects include tachycardia , palpitation s , hypotension , postural hypotension , and mild bradycardia . When your child feels one or more symptoms, ...

Palpitations

... Their cardiovascular effects include tachycardia , palpitations , hypotension , postural hypotension , and mild bradycardia . When your child feels one or more symptoms, ...

Aging

... PROBLEMS Heart and blood vessel disease s are fairly common in older people. Common disorders include high blood pressure and orthostatic hypotension . Aging , National Institute on (NIA): One of the US National Institutes of Health (NIH). Aging parents: Information you need in case of ...

Aging changes

... PROBLEMS Heart and blood vessel disease s are fairly common in older people. Common disorders include high blood pressure and orthostatic hypotension . Aging changes in the skin are a group of common conditions and developments that occur as people grow older. Pictures & Images Changes ...

Amnesia

... The adverse effects of benzodiazepine include sedation, perceptual disturbances, disorders of micturition and/or defecation, visual disturbances, hypotension , anterograde amnesia , psychological dependence , confusion , ataxia , ... Regional anesthesia can either be used alone or combined with ...

Arteriosclerosis

... that supply the legs and feet. Arteriosclerosis ( Hardening of the Arteries ) and Atherosclerosis (Plaque Development and Hardening) hypotension ( Low Blood Pressure ) Hypertension ( High Blood Pressure ) Stroke "1 ( Apoplexy ) Stroke "2 [Kellogg] # Triglycerides, Lowering ... ...

More>>

Hypotension in Biological Technology

Nile Therapeutics Announces Positive Results from Phase 1b Safety and Pharmacodynamics Study of CD-NP in Patients with Heart Failure

... up to an MTD of 20 ng/kg/min. Dose escalation was limited by symptoms of hypotension observed at 30 ng/kg/min, which represents a dose of approximately 3- to ... with favorable pharmacologic effects, but have also been associated with hypotension and decreased renal function which limit their utility in clinical ...

Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD-NP in Patients with Heart Failure

... right atrial pressure -- Trend toward increase in cardiac output -- No hypotension -- No change in serum creatinine About the Study The objective of the ... with favorable pharmacologic effects, but have also been associated with hypotension and decreased renal function which limit their utility in clinical ...

Centocor Ortho Biotech Data to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting

... including, but not limited to, flushing, shortness of breath, facial swelling, headache, chills, back pain, tightness in the chest or throat, and/or hypotension have occurred in up to 10% of patients treated with DOXIL. In most patients, these reactions have resolved within several hours to a day once the ...

Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting

... QT prolongation; neuroleptic malignant syndrome; tardive dyskinesia; hyperglycemia and diabetes mellitus; weight gain; seizures; orthostatic hypotension and syncope; leukopenia, neutropenia and agranulocytosis; hyperprolactinemia; body temperature regulation; dysphagia; suicide; priapism; potential ...

Nile Therapeutics Announces Focus on CD-NP for Acute Heart Failure and Termination of 2NTX-99 Program

... heart failure, including B-type natriuretic peptide, have been associated with favorable pharmacologic effects, but have also been associated with hypotension and decreased renal function which limit their utility in clinical practice. CD-NP was designed to preserve the favorable effects of current ...

Sangart, Inc. Announces Key Executive Appointments and Company Restructuring

... "Our recent successful Phase III clinical studies of Hemospan demonstrated very encouraging efficacy results for the prevention and treatment of hypotension in hip replacement procedures. These trials provide a platform from which to conduct the pivotal clinical studies that will be necessary to ...

Interim Analysis of Top-Line Data From Phase II/III Study Shows Favorable Efficacy & Safety for Corthera's Relaxin in Acute Heart Failure

... the current standard of care includes diuretics and vasodilators. Both of these classes of agents have been associated with renal impairment, hypotension and adverse outcomes. About Relaxin Relaxin is a naturally occurring peptide hormone that acts as a systemic and renal vasodilator. Elevated ...

Top-Line Preliminary Data From Phase II/III Study of Corthera's Relaxin in Acute Heart Failure to be Presented in Satellite Symposium at AHA Scientific Sessions 2008

... the current standard of care includes diuretics and vasodilators. Both of these classes of agents have been associated with renal impairment, hypotension and adverse outcomes. About Relaxin Relaxin is a naturally occurring peptide hormone that acts as a systemic and renal vasodilator. Elevated ...

FDA Approves Astellas' Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia

... patients (3%) than among placebo-treated patients (0%). Other common adverse reactions were headaches (8%, 10%), hypokalemia (22%, 10%), orthostatic hypotension (14%, 6%), and pyrexia (11%, 5%) for Vaprisol 20mg/day and 40mg/day, respectively. For full prescribing information, please visit ...

FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania

... (25-52% vs. 10-13%), dry mouth (12-37% vs. 1-7%), constipation (6-10% vs. 3-6%), dyspepsia (5-7% vs. 1-4%), dizziness (10-13% vs. 4-11%), orthostatic hypotension (7% vs. 5%), weight gain (7% vs. 1%), increased appetite (12% vs. 6%), fatigue (6-7% vs. 2-4%), dysarthria (5% vs. 0%), and nasal congestion (5% vs. ...
Hypotension in Biological Definition

Yellow fever

... proteinuria. If the disease progresses, delirium, seizures and coma ensue. hypotension and dehydration are also common. Mortality is around 5%. Patients who die ... Treatment is symptomatic and supportive only. Fluid replacement, fighting hypotension and transfusion of blood derivates is mostly needed in severe cases. In ...
Other Contents
(Date:7/2/2015)... VA (PRWEB) , ... July 02, 2015 , ... sweetFrog ... Albany, Mississippi. The opening is the first sweetFrog store located in Mississippi. The premium ... growing companies in 2014. , The store, located at 104 Railroad Avenue, New Albany, ...
(Date:7/2/2015)... ... , ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its ... in the Lone Star State. The premium frozen yogurt chain was listed as #22 ... which opened July 1 at Duke’s Travel Plaza, is located at:, 30176 Hwy 64, ...
(Date:7/2/2015)... Alexandria, VA (PRWEB) , ... July 02, 2015 ... ... applauds Congresswoman Donna Edwards (D-Md.) for her introduction of the Stop Overdose Stat ... bill introduced by Senator Jack Reed (D-R.I.), this Act seeks to decrease drug ...
(Date:7/2/2015)... , ... July 02, 2015 , ... Many Fourth of ... mind. That’s why Amica Insurance is sharing some tips to promote the ... approximately 230 people go to the emergency room daily with fireworks-related injuries in the ...
(Date:7/2/2015)... , ... July 02, 2015 , ... In 2012, Patrick Achebe realized that the gift ... alone. He sat down to write his first poem, and three years later he was ... was special and worth sharing with the world. "I have always believed that the best ...
Breaking Medicine News(10 mins):Health News:sweetfrog Opens First Location in Mississippi 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 3Health News:6 Fireworks Safety Tips from Amica Insurance 2Health News:Patrick Achebe Releases Debut Book, Whispering Waves: Poems for Everyday Grace 2
(Date:6/15/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... commerce market, announces that its leading payment security technology, the ... Experience! @ NYC June 18th. Digital Experience! @ ... in technology to over 300 of the top media covering ... Pavilion in New York City from ...
(Date:6/11/2015)... Va. , June 11, 2015 ... technology, announced today that its IdentityX Mobile Authentication ... (Fast IDentity Online) Alliance is an industry consortium ... open standards for simpler, stronger authentication.  In order ... must pass a rigorous series of tests that ...
(Date:6/9/2015)... Minn. , June 9, 2015   MedNet ... supports the entire spectrum of clinical research, will be ... eClinical technology platform at the 2015 Drug Information Association ... on June 15-17.  These presentations will include previews ... rolled out in the upcoming iMedNet 2015 ...
Breaking Biology News(10 mins):Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 2Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 3Daon's IdentityX Mobile Authentication Platform One of First Products to be Certified by FIDO Alliance 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 3
Other TagsOther Tags